Thursday, April 24, 2014

AdvaMed Worries ACOs Will Slow Adoption Of New Devices, Shift Costs

Medical device makers worry that accountable care organizations will substitute prescriptions drugs for clinical services and slow adoption of new devices that may cost more and are not yet the standard of care, even though those devices might be better for patients, according to executives of the Advanced Medical Technology Association.


You've followed a link to an article or document on InsideHealthPolicy.com.
There are three ways you can access this content.

Subscriber Login

If you are an InsideHealthPolicy.com subscriber, or you have an active trial subscription, please login here:

Take A Trial Subscription

If you haven't already had a trial subscription to InsideHealthPolicy.com, you can sign up for one right now. Just click on the link below to get started -- you'll get full access for one month, including access to our newsletters, Inside CMS and FDA Week, plus daily news updates by e-mail and much, much more.

Sign up for a trial subscription.

Buy This Article

You can also buy this and other individual InsideHealthPolicy.com articles by going to the InsideHealthPolicy.com NewsStand. Articles are $5 apiece. We'll even give you your first download free.

Here's a direct link to this article on the NewsStand.